Navigation Links
AstraZeneca Implements Customized Cytel East(R) Software for More Accurate Trial Monitoring and Clinical Data Analysis
Date:2/13/2009

Top Global Pharmaceutical Company Integrates Their Clinical Data System (CDS) and East(R) for Improved Clinical Data Handling and Trial Analysis

CAMBRIDGE, Mass., Feb. 13 /PRNewswire/ -- Cytel Inc. today announced that AstraZeneca International has expanded their deployment of Cytel's East(R) software, the most widely-used clinical trial design, simulation and monitoring system available. AstraZeneca's increased use of East(R) also features automated data transfer between their CDS and East's trial monitoring component. By eliminating manual data entry, AstraZeneca achieved the multiple benefits of greater clinical trial analysis efficiency and increased security of vital study data.

Cytel Vice President of Business Development, Steve Herbert, recalled the initial request: "AstraZeneca came to Cytel looking to improve data entry into East(R) from their own Clinical Data System (CDS). Our software engineers worked closely with their AstraZeneca's counterparts to help achieve far more efficient data handling within their CDS path and ensure compliance with Clinical Data Interchange Standards Consortium (CDISC) guidelines."

Maria Johansson, Business Tools Manager at AstraZeneca praised Cytel's response saying, "Cytel's customized version of East(R) for AstraZeneca is now fully integrated with our clinical data system eliminating any manual data handling and better facilitating the data analysis process. This new automation also helps us maintain the integrity of the interim data, reducing the risk of unintentional un-blinding."

Of the experience, Mrs. Johansson remarked, "The cooperation between As
'/>"/>

SOURCE Cytel Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. AstraZeneca Appoints Graham Baker Vice President and Chief Financial Officer for North America
2. AstraZeneca Nobel Medicine Initiative to Increase Interest in the Nobel Prize in Physiology or Medicine
3. AstraZeneca and M. D. Anderson Renew Cancer Research Collaboration
4. FDA Approves AstraZenecas SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania
5. Melior Enters Research Collaboration with AstraZeneca
6. Abbott and AstraZeneca Expand Relationship to Include Co-Promotion of CRESTOR(R)
7. AstraZeneca Survey: Healthcare Professionals Leading Source of Information on Companys Prescription Savings Programs
8. Weitz & Luxenberg Files Seroquel Diabetes Lawsuit Against AstraZeneca
9. Cellectricon and AstraZeneca - Partners in New High Throughput Ion Channel Drug Discovery Technology
10. WuXi PharmaTech (NYSE: WX) Expands Collaboration With AstraZeneca
11. AstraZeneca Supports Transparency Legislation on Payments to Health Care Providers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)HOPKINTON, Mass., Dec. 3 Caliper Life Sciences, Inc. (Nasdaq: CALP ), a leading provider of tools and services for drug discovery and life sciences research, today introduced Living Image 4.0 softwa
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Carbondioxide Incubators - A Global Market Perspective ,, http://www.reportlinker.co
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
(Date:12/2/2009)SINGAPORE, Dec. 2 S*BIO Pte Ltd today announced data presentations on its novel oral JAK2 inhibitor, SB1518, at The American Society of Hematology 51st Annual Meeting and Exposition in New Orleans. ,
Breaking Biology Technology:Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5
...ell Report Identifies SPINK1 as a New Biomarker fo...pendia Bioscience, Inc.,the leading provider of ca...unced the central role of their flagship product O... SPINK1 as a key new therapeutic target and,biomar...rowing compendium of nearly 26,000 gene,expression...
...publication on utility of PRDT,s prion reduction t...utzfeldt-Jakob Disease ("vCJD") from ...ing lunchtime Symposium at meeting to discuss prio... product quality., MONTREAL, Canada and CAMBRIDGE... ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic"...
... Iris Recognition Algorithm Detects and Compensate...ctions, VILNIUS, Lithuania, June 10 Neurotechnol...ecognition technology to the,company,s suite of bi...elopment products. VeriEye SDK features an advance...and compensates for partial obstructions,irregular...
Other Biology Technology:Oncomine(TM) Again Key to Prostate Cancer Discovery 2ProMetic announces Octapharma publication of PRDT'S prion removal resin in Octaplas(R) manufacturing process at 30th International Congress of the International Society for Blood Transfusion meeting in Macao SAR, China 2ProMetic announces Octapharma publication of PRDT'S prion removal resin in Octaplas(R) manufacturing process at 30th International Congress of the International Society for Blood Transfusion meeting in Macao SAR, China 3ProMetic announces Octapharma publication of PRDT'S prion removal resin in Octaplas(R) manufacturing process at 30th International Congress of the International Society for Blood Transfusion meeting in Macao SAR, China 4ProMetic announces Octapharma publication of PRDT'S prion removal resin in Octaplas(R) manufacturing process at 30th International Congress of the International Society for Blood Transfusion meeting in Macao SAR, China 5ProMetic announces Octapharma publication of PRDT'S prion removal resin in Octaplas(R) manufacturing process at 30th International Congress of the International Society for Blood Transfusion meeting in Macao SAR, China 6New VeriEye SDK from Neurotechnology Enables Development of Reliable, Cost-effective Biometric Iris Recognition Systems 2New VeriEye SDK from Neurotechnology Enables Development of Reliable, Cost-effective Biometric Iris Recognition Systems 3
(Date:12/4/2009)By measuring the total gene activity in organs relevant for coronary artery disease (CAD), scientists at the Swedish medical university Karolinska Institutet have identified a module of genes that is
(Date:12/4/2009)This release is available in German . , A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing. Previou
(Date:12/3/2009)WALL, N.J., Dec. 3 BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in wireless public safety and finger-based biometric identification solutions, announced that a majority of its sha
Breaking Biology News(10 mins):Scientists discover gene module underlying atherosclerosis development 2How nutrition affects healthy aging 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3DURECT Corporation Invites You to Join its Third Quarter 2009 Earnings Conference Call 5704 1DURECT Corporation Invites You to Join its Third Quarter 2009 Earnings Conference Call 5704 2Exposure to Holocaust May Have Raised Cancer Risks 60111 1Exposure to Holocaust May Have Raised Cancer Risks 60111 2Heart Disease Gender Gap Narrows 60108 1Heart Disease Gender Gap Narrows 60108 2Heart Disease Gender Gap Narrows 60108 3
...onal size guidelines for all-terrain vehicles (ATV...ers, according to preliminary results from a study...ased on initial experiments, the researchers found...h match the rider,s age to a recommended vehicle f...hough results are preliminary and the initial expe...
...AM, N.C. By coupling a kicked-up version of micro...rsity scientists are now able to peer so deep into...ting. , If future studies in animal models prove ...pproach can have a wide spectrum of clinical appli...t is removed from the body to assessing the effect...
...w advance in cellular imaging is allowing scientis...he area around tumors, also known as the tumor mic...isease Models & Mechanisms (DMM), dmm.biologists...hods of laser microscopy to track the movement of ... As a tumor grows, it triggers immune responses in...
Other Biology News:Study finds ATV guidelines inadequate 2New technique sees into tissue at greater depth, resolution 2New technique sees into tissue at greater depth, resolution 3
...cessory lessens the expensive task of validating m... mass spectrometers. It converts the unprocessed d...quadrupole mass spectrometers into analog format a...ory information management (LIMS) systems for proc...
...were designed for full-length gene cloning and req...ed cDNA clone. The first PCR analysis is performed...ains plasmid DNA from 5,000 clones. Having identif... the reaction products, the second PCR analysis is...
...were designed for full-length gene cloning and req...ed cDNA clone. The first PCR analysis is performed...ains plasmid DNA from 5,000 clones. Having identif... the reaction products, the second PCR analysis is...
...tide Kit, designed for use with Ciphergens Protein... peptides more straightforward and faster than eve...cations - Monitor beta-amyloid expression after dr...ls with disease progression - Evaluate mechanisms ...
Biology Products: